David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
PUT
Texas Pacific Land
TPL
$25.5B
| $2.89M | ﹤0.01% |
+6,100
| New | +$2.62M |
|
2527
CALL
Arbor Realty Trust
ABR
$938M
| $2.89M | ﹤0.01% |
375,100
+125,100
| +50% | +$975K |
|
2528
VanEck Uranium + Nuclear Energy ETF
NLR
$4.39B
| $2.89M | ﹤0.01% |
21,668
-55,546
| -72% | -$7.94M |
|
|
NFBK
2529
DELISTED
Northfield Bancorp
NFBK
| $2.88M | ﹤0.01% |
212,842
+23,685
| +13% | +$305K |
|
2530
iShares MSCI South Africa ETF
EZA
$594M
| $2.88M | ﹤0.01% |
42,457
+26,025
| +158% | +$1.89M |
|
2531
BioCryst Pharmaceuticals
BCRX
$2.52B
| $2.88M | ﹤0.01% |
302,101
-945,365
| -76% | -$7.34M |
|
2532
PUT
JetBlue
JBLU
$1.85B
| $2.87M | ﹤0.01% |
650,000
-166,200
| -20% | -$843K |
|
2533
El Pollo Loco
LOCO
$463M
| $2.87M | ﹤0.01% |
206,841
+55,762
| +37% | +$639K |
|
2534
Invesco WilderHill Clean Energy ETF
PBW
$400M
| $2.86M | ﹤0.01% |
90,605
-214,023
| -70% | -$7.14M |
|
2535
National Bank Holdings
NBHC
$1.84B
| $2.86M | ﹤0.01% |
73,047
-75,928
| -51% | -$3.04M |
|
2536
Aviat Networks
AVNW
$277M
| $2.86M | ﹤0.01% |
126,464
-2,716
| -2% | -$64.9K |
|
2537
CALL
Marriott Vacations Worldwide
VAC
$3.83B
| $2.86M | ﹤0.01% |
43,900
+33,300
| +314% | +$2.06M |
|
2538
Aspen Aerogels
ASPN
$434M
| $2.85M | ﹤0.01% |
833,572
+810,355
| +3,490% | +$2.73M |
|
2539
CALL
Tapestry
TPR
$24.6B
| $2.85M | ﹤0.01% |
20,200
-20,300
| -50% | -$2.88M |
|
|
GRDN
2540
Guardian Pharmacy Services
GRDN
$2.36B
| $2.85M | ﹤0.01% |
75,683
-10,846
| -13% | -$354K |
|
2541
Bumble
BMBL
$358M
| $2.85M | ﹤0.01% |
873,633
-2,148,304
| -71% | -$7.14M |
|
2542
CALL
Biogen
BIIB
$32.7B
| $2.84M | ﹤0.01% |
15,500
+2,300
| +17% | +$424K |
|
2543
Harmony Biosciences
HRMY
$2.32B
| $2.84M | ﹤0.01% |
101,427
-12,883
| -11% | -$422K |
|
2544
Rhythm Pharmaceuticals
RYTM
$7.75B
| $2.84M | ﹤0.01% |
32,652
+1,296
| +4% | +$126K |
|
2545
Voya Financial
VOYA
$9.16B
| $2.84M | ﹤0.01% |
41,510
-39,143
| -49% | -$2.84M |
|
2546
Bioventus
BVS
$942M
| $2.84M | ﹤0.01% |
310,610
-47,647
| -13% | -$400K |
|
2547
Paysafe
PSFE
$351M
| $2.83M | ﹤0.01% |
415,917
+283,285
| +214% | +$2.01M |
|
2548
Phinia Inc
PHIN
$2.49B
| $2.83M | ﹤0.01% |
41,360
-110,381
| -73% | -$7.71M |
|
2549
Ternium
TX
$11B
| $2.83M | ﹤0.01% |
+70,406
| New | +$2.92M |
|
2550
CALL
Delek US
DK
$4.3B
| $2.83M | ﹤0.01% |
62,700
-39,700
| -39% | -$1.42M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.